Cargando…

The Promises of Natural Killer Cell Therapy in Endometriosis

Endometriosis is a gynaecological disease defined by the growth of endometrium-like tissue outside the uterus. The disease is present in approximately 5–10% of women of reproductive age and causes pelvic pain and infertility. The pathophysiology is not completely understood, but retrograde menstruat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoogstad-van Evert, Janneke, Paap, Romy, Nap, Annemiek, van der Molen, Renate
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146217/ https://www.ncbi.nlm.nih.gov/pubmed/35628346 http://dx.doi.org/10.3390/ijms23105539

Ejemplares similares

Endometriosis and the effects of dietary interventions: what are we looking for?
por: Nap, Annemiek, et al.
Publicado: (2022)

Natural Killer Cell Receptors and Endometriosis: A Systematic Review
por: Reis, José Lourenço, et al.
Publicado: (2022)

Natural Killer Cells: A Promising Kit in the Adoptive Cell Therapy Toolbox
por: Xiao, Jiani, et al.
Publicado: (2022)

Decreased Cytotoxicity of Peripheral and Peritoneal Natural Killer Cell in Endometriosis
por: Jeung, InCheul, et al.
Publicado: (2016)

Natural killer cells: a promising immunotherapy for cancer
por: Chu, Junfeng, et al.
Publicado: (2022)

The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection
por: Rajaram, Sanjeeth, et al.
Publicado: (2020)

Barriers and facilitators to the timely diagnosis of endometriosis in primary care in the Netherlands
por: van der Zanden, Moniek, et al.
Publicado: (2019)

Effect of Helixor A on Natural Killer Cell Activity in Endometriosis
por: Jeung, In-Cheul, et al.
Publicado: (2015)

Involvement of natural killer cells in the pathogenesis of endometriosis in patients with pelvic pain
por: He, Jue, et al.
Publicado: (2020)

Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy
por: Wang, Yan, et al.
Publicado: (2023)

Natural killer cell-based therapies
por: Romagné, François, et al.
Publicado: (2011)

Endometriosis centers of expertise in the Netherlands: Development toward regional networks of multidisciplinary care
por: de Kok, Laura, et al.
Publicado: (2022)

ESHRE guideline: endometriosis(†)
por: Becker, Christian M, et al.
Publicado: (2022)

Natural killer cells in cancer biology and therapy
por: Wu, Song-Yang, et al.
Publicado: (2020)

Viral Infection of Human Natural Killer Cells
por: van Erp, Elisabeth A., et al.
Publicado: (2019)

Roles of Natural Killer T Cells and Natural Killer Cells in Kidney Injury
por: Uchida, Takahiro, et al.
Publicado: (2019)

Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis?
por: Guan, Qihui, et al.
Publicado: (2023)

Advanced T and Natural Killer Cell Therapy for Glioblastoma
por: Yoon, Wan-Soo, et al.
Publicado: (2023)

Invariant Natural Killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis
por: Correa, Frederico J.S., et al.
Publicado: (2022)

Enhancing the use of natural killer cells as a promising therapy against monkeypox: Mechanisms and implications
por: Mehta, Kahan, et al.
Publicado: (2023)

Antitumor Immunity Exerted by Natural Killer and Natural Killer T Cells in the Liver
por: Nakashima, Hiroyuki, et al.
Publicado: (2023)

Infections, Reactions of Natural Killer T Cells and Natural Killer Cells, and Kidney Injury
por: Uchida, Takahiro, et al.
Publicado: (2022)

Understanding of molecular mechanisms in natural killer cell therapy
por: Yoon, Suk Ran, et al.
Publicado: (2015)

Natural Born Killers: NK Cells in Cancer Therapy
por: Franks, S. Elizabeth, et al.
Publicado: (2020)

Intraperitoneal infusion of ex vivo-cultured allogeneic NK cells in recurrent ovarian carcinoma patients (a phase I study)
por: Hoogstad-van Evert, Janneke, et al.
Publicado: (2019)

Immunotherapy: A promising novel endometriosis therapy
por: Li, Wenshu, et al.
Publicado: (2023)

Cord Blood-Derived Natural Killer Cell Exploitation in Immunotherapy Protocols: More Than a Promise?
por: Damele, Laura, et al.
Publicado: (2022)

Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
por: Iyoda, Tomonori, et al.
Publicado: (2023)

Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response
por: Toffoli, Elisa C., et al.
Publicado: (2021)

Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular Therapies
por: Hofer, Erhard, et al.
Publicado: (2017)

Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising Natural Killer T Cell–based Therapy
por: Wang, Zi-Hao, et al.
Publicado: (2023)

Natural killer cells and autoimmunity
por: French, Anthony R, et al.
Publicado: (2004)

Natural Killer Cell-Mediated Cellular Therapy of Hematological Malignancies
por: Sahin, Ugur, et al.
Publicado: (2019)

Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients
por: Hoogstad-van Evert, Janneke S., et al.
Publicado: (2018)

Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic Review
por: Chan, Alvin Man Lung, et al.
Publicado: (2023)

Allogeneic natural killer cell therapy
por: Berrien-Elliott, Melissa M., et al.
Publicado: (2023)

A promising future for endometriosis diagnosis and therapy: extracellular vesicles - a systematic review
por: Scheck, Simon, et al.
Publicado: (2022)

A Killer Disarmed: Natural Killer Cell Impairment in Myelodysplastic Syndrome
por: Arellano-Ballestero, Helena, et al.
Publicado: (2023)

Natural Killer Cell Dysfunction and Its Role in COVID-19
por: van Eeden, Charmaine, et al.
Publicado: (2020)

The role of natural killer cell in gastrointestinal cancer: killer or helper
por: Wang, Feixue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_23fsjkrm0qkc4n9f05ml9rvo2b